Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,426 | 59,883 | 12,463 | 7,070 | 37,765 |
| Marketable Securities | 0 | 0 | 8,012 | 22,516 | N/A |
| Receivables | 8,371 | N/A | N/A | N/A | N/A |
| Inventories | 2,691 | 1,135 | N/A | N/A | N/A |
| TOTAL | $61,755 | $61,976 | $22,339 | $30,334 | $38,672 |
| Non-Current Assets | |||||
| PPE Net | 2,460 | 2,430 | 2,478 | 2,562 | 2,591 |
| Intangibles | 6,340 | 6,506 | 6,673 | 6,839 | 7,005 |
| Other Non-Current Assets | 9,484 | 9,645 | 9,803 | 9,960 | 10,114 |
| TOTAL | $18,284 | $18,581 | $18,954 | $19,361 | $19,710 |
| Total Assets | $80,039 | $80,557 | $41,293 | $49,695 | $58,382 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 118 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,823 | 2,164 | 1,717 | 1,432 | 1,489 |
| Accrued Expenses | 4,572 | 5,617 | 5,326 | 4,111 | 3,123 |
| TOTAL | $9,844 | $8,528 | $7,585 | $6,000 | $4,890 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 41,000 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 10,445 | 10,632 | 10,814 | 10,991 | 11,164 |
| TOTAL | $10,445 | $51,632 | $10,814 | $10,991 | $11,164 |
| Total Liabilities | $20,289 | $60,160 | $18,399 | $16,991 | $16,054 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,606 | 26,460 | 26,087 | 25,342 | 25,212 |
| Common Shares | 29 | 26 | 25 | 25 | 25 |
| Retained earnings | -206,502 | -191,179 | -172,540 | -158,790 | -145,894 |
| Other shareholders' equity | 0 | 0 | -1 | 1 | 0 |
| TOTAL | $59,750 | $20,397 | $22,894 | $32,704 | $42,328 |
| Total Liabilities And Equity | $80,039 | $80,557 | $41,293 | $49,695 | $58,382 |